First in Human Study of ANXV (Recombinant Human Annexin A5) in Healthy Volunteers
Condition(s):HealthyLast Updated:May 16, 2022Completed
Hide Studies Not Open or Pending
Condition(s):HealthyLast Updated:May 16, 2022Completed
Condition(s):Aortic Valve StenosisLast Updated:March 29, 2023Active, not recruiting
Condition(s):Covid19-associated ARDS; Covid19; ARDSLast Updated:March 24, 2021Completed
Condition(s):Acute Myeloid Leukemia, Adult; Myelodysplastic SyndromesLast Updated:March 20, 2023Active, not recruiting
Condition(s):Corneal Disease; Corneal Opacity; Corneal InjuriesLast Updated:December 16, 2022Active, not recruiting
Condition(s):Tricuspid RegurgitationLast Updated:March 14, 2023Recruiting
Condition(s):Nonalcoholic SteatohepatitisLast Updated:April 20, 2022Completed
Condition(s):HealthyLast Updated:May 2, 2019Completed
Condition(s):Rheumatoid ArthritisLast Updated:March 13, 2023Recruiting
Condition(s):Healthy SubjectsLast Updated:March 16, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.